Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
797 JPY | +0.50% | +2.05% | -32.00% |
21/03 | US Fed Rate Outlook Catapults Japanese Shares to Fresh 52-Week Peak | MT |
21/03 | JCR Pharmaceuticals Achieves Neurodegenerative Treatment Research Milestone With Alexion | MT |
Business Summary
Number of employees: 879
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 51,082 | 100.0 % | 34,343 | 100.0 % | -32.77% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 51,082 | 100.0 % | 34,343 | 100.0 % | -32.77% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Shin Ashida
CEO | Chief Executive Officer | 81 | 13/75/13 |
Hiroyuki Sonoda
CTO | Chief Tech/Sci/R&D Officer | 45 | 01/03/01 |
Yutaka Honda
ADM | Chief Administrative Officer | - | - |
Yoshio Hiyama
BRD | Director/Board Member | - | 01/19/01 |
Mathias Schmidt
BRD | Director/Board Member | 56 | 01/20/01 |
Takashi Suetsuna
BRD | Director/Board Member | 75 | 01/16/01 |
Toru Ashida
BRD | Director/Board Member | 55 | 01/14/01 |
Masaki Sumiyoshi
HRO | Human Resources Officer | - | - |
Masaya Ichikawa
AUD | Comptroller/Controller/Auditor | - | - |
Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Shin Ashida
CEO | Chief Executive Officer | 81 | 13/75/13 |
Philippe Fauchet
BRD | Director/Board Member | 65 | - |
Toru Ashida
BRD | Director/Board Member | 55 | 01/14/01 |
Director/Board Member | 71 | 01/15/01 | |
Takashi Suetsuna
BRD | Director/Board Member | 75 | 01/16/01 |
Yutaka Atomi
BRD | Director/Board Member | 79 | - |
Yuko Hayashi
BRD | Director/Board Member | 59 | 27/18/27 |
Hiroyuki Sonoda
CTO | Chief Tech/Sci/R&D Officer | 45 | 01/03/01 |
Mathias Schmidt
BRD | Director/Board Member | 56 | 01/20/01 |
Yoshio Hiyama
BRD | Director/Board Member | - | 01/19/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 129,686,308 | 68,693,394 ( 52.97 %) | 4,884,914 ( 3.767 %) | 52.97 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
4,585,900 | 3.54% | 26,028,514 $ | |
204,000 | 0.54% | 4,340,282 $ |
Company contact information
JCR Pharmaceuticals Co., Ltd.
3-19 Kasuga-cho
659-0021, Ashiya
+81 7 9732 8591
http://www.jcrpharm.co.jpSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.00% | 632M | |
+25.68% | 661B | |
+27.00% | 566B | |
-6.21% | 352B | |
+20.49% | 332B | |
+3.53% | 283B | |
+14.36% | 231B | |
+5.10% | 200B | |
-9.00% | 195B | |
-5.06% | 145B |
- Stock Market
- Equities
- 4552 Stock
- Company JCR Pharmaceuticals Co., Ltd.